Keyphrases
Methylation Changes
100%
Magnesium Treatment
100%
Transmembrane Protease Serine 2 (TMPRSS2)
100%
5-hydroxymethylcytosine (5hmC)
75%
Placebo
50%
False Discovery Rate
50%
Genotype
25%
DNA Methylation (DNAm)
25%
Early Disease
25%
Colorectal Cancer
25%
Cancer Clinical Trials
25%
Methylation
25%
Randomized Controlled Trial
25%
Viral Entry
25%
Personalized Prevention
25%
Individual Age
25%
Magnesium
25%
Magnesium Intake
25%
5′-untranslated Region (5′-UTR)
25%
Close Proximity
25%
COVID-19
25%
Viral Spike Protein
25%
COVID-19 Prevention
25%
COVID-19 Treatment
25%
Adjusting for Covariates
25%
Mild Disease
25%
Vanderbilt University Medical Center
25%
Intake Ratio
25%
TMPRSS2 Gene
25%
5-Methylcytosine Methylation
25%
Protein Priming
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
5 Hydroxymethylcytosine
100%
5 Methylcytosine
100%
Serine Proteinase
100%
Randomized Controlled Trial
50%
SARS Coronavirus
50%
Virus Spike Protein
50%
Colorectal Carcinoma
50%
Diseases
50%
Biochemistry, Genetics and Molecular Biology
Methylation
100%
TMPRSS2
100%
Serine Protease
100%
Promoter Region
40%
5-Hydroxymethylcytosine
40%
5-Methylcytosine
40%
Genotyping
20%
Randomized Controlled Trial
20%
DNA Methylation
20%
Virus Entry
20%
Untranslated Region
20%
SARS Coronavirus
20%
Virus Spike
20%